The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  CareDx, another monster Date:  1/18/2021  6:50 PM
Author:  Fuma102 Number:  25559 of 25631

They don't really have competition.

Theyre integrating into EMR, reducing headaches on medical providers. They own transplant markets and doing gobs of research. High margin business too.

There's alot to like here. This honestly could/should be a rule breaker or Saul stock.

It's growing 50% or more yoy with 70% margins. Saas companies are 20-35x price:sales with margins this high. At 200m/year, 20x puts them at about 4b, which is where they are currently valued. With a TAM in the billions- and very likely to hit that number in the next 5 or so years- CareDx seems like it could be a pretty safe set it and forget it winner.

If there is a sure thing in biotech, this comes awfully close. I struggle to see how this doesn't outperform over the next 3-5 years even after it's recent run up.
Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us